NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of sellers of common stock of Masonite InternationalNEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of sellers of common stock of Masonite International

Rosen Law Firm Urges Masonite International Corporation (NYSE: DOOR) Stockholders to Contact the Firm for Information About Their Rights

2026/02/10 11:45
Okuma süresi: 3 dk

NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of sellers of common stock of Masonite International Corporation (NYSE: DOOR) between June 5, 2023 and February 8, 2024. Masonite describes itself as a “leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for the residential and non-residential building construction markets’ new construction and repair, renovation and remodeling sectors.”

For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.

The Allegations: Rosen Law Firm is Investigating the Allegations that Masonite International Corporation (NYSE: DOOR) Misled Investors Regarding its Business Operations.

According to the lawsuit, throughout the Class Period, defendants made material omissions and misrepresentations concerning Owens Corning’s offers to purchase all of Masonite’s outstanding common stock at significant premiums to Masonite’s stock price and Masonite’s repurchases of millions of dollars’ worth of its shares without disclosing material nonpublic information about Owens Corning’s offers, which, if disclosed as required, would have indicated to investors that Masonite’s stock was worth significantly more.

What Now: You may be eligible to participate in the class action against Masonite International Corporation. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by April 7, 2026. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

Piyasa Fırsatı
Common Protocol Logosu
Common Protocol Fiyatı(COMMON)
$0.0005269
$0.0005269$0.0005269
-12.37%
USD
Common Protocol (COMMON) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.